These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3141343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
    Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E.
    Clin Pharmacokinet; 1990 Jul; 19(1):80-8. PubMed ID: 2116257
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
    Nakashima M, Kanamaru M, Uematsu T, Takiguchi A, Mizuno A, Itaya T, Kawahara F, Ooie T, Saito S, Uchida H.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
    [Abstract] [Full Text] [Related]

  • 9. Altered disposition of fleroxacin in patients with cystic fibrosis.
    Mimeault J, Vallée F, Seelmann R, Sörgel F, Ruel M, LeBel M.
    Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750
    [Abstract] [Full Text] [Related]

  • 10. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E, Portmann R, Partos C, Dell D.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of fleroxacin in man.
    Sörgel F, Seelmann R, Naber K, Metz R, Muth P.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():169-78. PubMed ID: 3144535
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE, Frey FJ, Heizmann P, Brandt R, Weidekamm E.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK, Rao GS, Ramesh S, Muruganandan S, Tripathi HC, Shukla DC.
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
    Chukwuani CM, Coker HA, Oduola AM, Sowunmi A, Ifudu ND.
    Biol Pharm Bull; 2000 Aug; 23(8):968-72. PubMed ID: 10963305
    [Abstract] [Full Text] [Related]

  • 15. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
    Weidekamm E, Portmann R, Suter K, Partos C, Dell D, Lücker PW.
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC, Bergeron MG, LeBel M.
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
    [Abstract] [Full Text] [Related]

  • 17. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y, Kim TH, Tao X, Kinzig M, Landersdorfer CB, Drescher SK, Sutaria DS, Moya B, Holzgrabe U, Sörgel F, Bulitta JB.
    Eur J Pharm Sci; 2018 Oct 15; 123():416-428. PubMed ID: 30076955
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
    Sorgel F, Metz R, Naber K, Seelmann R, Muth P.
    J Antimicrob Chemother; 1988 Oct 15; 22 Suppl D():155-67. PubMed ID: 3144534
    [Abstract] [Full Text] [Related]

  • 19. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
    Soussy CJ, Leclercq R, Deforges L, Duval J.
    Pathol Biol (Paris); 1989 May 15; 37(5):364-9. PubMed ID: 2506511
    [Abstract] [Full Text] [Related]

  • 20. Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.
    Martínez MA, Ares I, Rodríguez JL, Martínez M, Martínez-Larrañaga MR, Isea G, Anadón A.
    Front Vet Sci; 2017 May 15; 4():77. PubMed ID: 28596959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.